应对 COVID-19 大流行期间血液系统恶性肿瘤患者的治疗方法。
Treatment Approaches for Managing Patients with Hematological Malignancies in the Time of COVID-19 Pandemic.
机构信息
Department of Hematology, Faculty of Medicine, Ankara University, Ankara, Turkey.
出版信息
Turk J Med Sci. 2021 Dec 13;51(6):2799-2809. doi: 10.3906/sag-2101-276.
Abstract
BACKGROUND/AIM: The COVID-19 pandemic is a unique challenge to the care of patients with hematological malignancies. We aim to provide supportive guidance to clinicians making individual patients decisions during the COVID-19 pandemic, in particular during periods that access to healthcare resources may be limited.
CONCLUSION
This review also provides recommendations, which are convenient in evaluating indications for therapy, reducing therapy-associated immunosuppression, and reducing healthcare utilization in patients with specific hematological malignancies in the COVID-19 era. Specific decisions regarding treatment of hematological malignancies will need to be individualized, based on disease risk, risk of immunosuppression, rates of community transmission of SARS-CoV-2, and available local healthcare resources.
摘要
背景/目的：COVID-19 大流行是对血液系统恶性肿瘤患者护理的独特挑战。我们的目标是为临床医生在 COVID-19 大流行期间，特别是在获得医疗资源可能受到限制的时期，为患者做出个人决策提供支持性指导。
结论
本综述还提供了建议，这些建议有助于评估治疗适应症、减少与治疗相关的免疫抑制以及减少 COVID-19 时代特定血液系统恶性肿瘤患者的医疗保健利用。血液系统恶性肿瘤的治疗决策需要个体化，具体取决于疾病风险、免疫抑制风险、SARS-CoV-2 在社区中的传播率以及当地可用的医疗保健资源。
相似文献
1
Treatment Approaches for Managing Patients with Hematological Malignancies in the Time of COVID-19 Pandemic.应对 COVID-19 大流行期间血液系统恶性肿瘤患者的治疗方法。
Turk J Med Sci. 2021 Dec 13;51(6):2799-2809. doi: 10.3906/sag-2101-276.
2
Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic.澳大利亚和新西兰在 COVID-19 大流行期间关于淋巴瘤、慢性淋巴细胞白血病和骨髓瘤管理的共识声明。
Intern Med J. 2020 Jun;50(6):667-679. doi: 10.1111/imj.14859. Epub 2020 May 15.
3
The management of hematologic malignancies during the COVID-19 pandemic.COVID-19 大流行期间血液系统恶性肿瘤的管理。
Expert Opin Pharmacother. 2021 Apr;22(5):565-582. doi: 10.1080/14656566.2020.1849143. Epub 2020 Dec 21.
4
The impact of COVID-19 on patients with hematological malignancies: the mixed-method analysis of an Israeli national survey.COVID-19 对血液系统恶性肿瘤患者的影响：一项以色列全国调查的混合方法分析。
Support Care Cancer. 2021 Dec;29(12):7591-7599. doi: 10.1007/s00520-021-06324-4. Epub 2021 Jun 14.
5
Managing patients with hematological malignancies during COVID-19 pandemic.在新冠疫情期间管理血液系统恶性肿瘤患者
Expert Rev Hematol. 2020 Aug;13(8):787-793. doi: 10.1080/17474086.2020.1787147. Epub 2020 Jul 12.
6
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus.在2019冠状病毒病大流行期间管理血液系统癌症患者：ESMO-EHA跨学科专家共识
ESMO Open. 2022 Apr;7(2):100403. doi: 10.1016/j.esmoop.2022.100403. Epub 2022 Jan 28.
7
COVID-19 and seasonal influenza: a comparative analysis in patients with hematological malignancies.COVID-19 与季节性流感：血液系统恶性肿瘤患者的对比分析。
Leuk Lymphoma. 2022 Mar;63(3):664-671. doi: 10.1080/10428194.2021.1992626. Epub 2021 Oct 20.
8
Factors associated with SARS-CoV-2 infection and outcome in patients with solid tumors or hematological malignancies: a single-center study.与实体瘤或血液系统恶性肿瘤患者 SARS-CoV-2 感染和结局相关的因素：一项单中心研究。
Support Care Cancer. 2021 Nov;29(11):6271-6278. doi: 10.1007/s00520-021-06175-z. Epub 2021 Apr 14.
9
Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies.土耳其血液系统恶性肿瘤患者 COVID-19 的临床特征和结局。
Turk J Haematol. 2022 Feb 23;39(1):43-54. doi: 10.4274/tjh.galenos.2021.2021.0287. Epub 2021 Sep 15.
10
COVID-19 in hematological malignancies: Case series and literature review.COVID-19 与血液系统恶性肿瘤：病例系列与文献复习。
Ann Afr Med. 2023 Jul-Sep;22(3):381-384. doi: 10.4103/aam.aam_238_21.
本文引用的文献
1
Management of Patients With Hematologic Malignancies During the COVID-19 Pandemic: Practical Considerations and Lessons to Be Learned.2019冠状病毒病大流行期间血液系统恶性肿瘤患者的管理：实际考量与经验教训
Front Oncol. 2020 Aug 14;10:1439. doi: 10.3389/fonc.2020.01439. eCollection 2020.
2
Managing patients with hematological malignancies during COVID-19 pandemic.在新冠疫情期间管理血液系统恶性肿瘤患者
Expert Rev Hematol. 2020 Aug;13(8):787-793. doi: 10.1080/17474086.2020.1787147. Epub 2020 Jul 12.
3
Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts.2019冠状病毒病（COVID-19）时代成人急性白血病和髓系肿瘤患者管理的特殊考量：国际专家小组的建议
Lancet Haematol. 2020 Aug;7(8):e601-e612. doi: 10.1016/S2352-3026(20)30205-2. Epub 2020 Jun 18.
4
Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation.新型冠状病毒肺炎疫情期间急性白血病患者的管理：欧洲血液与骨髓移植学会急性白血病工作组实用指南
Bone Marrow Transplant. 2021 Mar;56(3):532-535. doi: 10.1038/s41409-020-0970-x. Epub 2020 Jun 11.
5
Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN).COVID-19 大流行时代多发性骨髓瘤患者的管理：来自欧洲骨髓瘤网络（EMN）的共识文件。
Leukemia. 2020 Aug;34(8):2000-2011. doi: 10.1038/s41375-020-0876-z. Epub 2020 May 22.
6
Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic.澳大利亚和新西兰在 COVID-19 大流行期间关于淋巴瘤、慢性淋巴细胞白血病和骨髓瘤管理的共识声明。
Intern Med J. 2020 Jun;50(6):667-679. doi: 10.1111/imj.14859. Epub 2020 May 15.
7
Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses.美国德克萨斯州中北部地区 2019 年新型冠状病毒感染的早期趋势及其对其他循环呼吸道病毒的影响
J Med Virol. 2020 Oct;92(10):2130-2138. doi: 10.1002/jmv.26010. Epub 2020 Jun 2.
8
The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy.COVID-19 和造血细胞移植面临的挑战；EBMT 关于造血细胞移植受者、供者和接受 CAR-T 细胞治疗患者管理的建议。
Bone Marrow Transplant. 2020 Nov;55(11):2071-2076. doi: 10.1038/s41409-020-0919-0. Epub 2020 May 13.
9
Treating Leukemia in the Time of COVID-19.在 COVID-19 期间治疗白血病。
Acta Haematol. 2021;144(2):132-145. doi: 10.1159/000508199. Epub 2020 May 11.
10
Considerations for Managing Patients With Hematologic Malignancy During the COVID-19 Pandemic: The Seattle Strategy.应对 COVID-19 大流行期间血液系统恶性肿瘤患者的管理策略：西雅图方案。
JCO Oncol Pract. 2020 Sep;16(9):571-578. doi: 10.1200/OP.20.00241. Epub 2020 May 5.
Zotero 插件